Cargando…

Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens

Detalles Bibliográficos
Autores principales:	Fang, Zhenhao, Monteiro, Valter S., Renauer, Paul A., Shang, Xingbo, Suzuki, Kazushi, Ling, Xinyu, Bai, Meizhu, Xiang, Yan, Levchenko, Andre, Booth, Carmen J., Lucas, Carolina, Chen, Sidi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988199/ https://www.ncbi.nlm.nih.gov/pubmed/36879038 http://dx.doi.org/10.1038/s41422-023-00792-5

Ejemplares similares

Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
por: Fang, Zhenhao, et al.
Publicado: (2022)

Multiplexed activation of endogenous genes by CRISPRa elicits potent anti-tumor immunity
por: Wang, Guangchuan, et al.
Publicado: (2019)

Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
por: Ren, Ping, et al.
Publicado: (2023)

Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
por: Ren, Ping, et al.
Publicado: (2023)

Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
por: Peng, Lei, et al.
Publicado: (2022)

Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
por: Peng, Lei, et al.
Publicado: (2022)

The Value of Polyvalent Serum
por: Dunlop, C. W.
Publicado: (1912)

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
por: Fang, Zhenhao, et al.
Publicado: (2022)

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
por: Fang, Zhenhao, et al.
Publicado: (2022)

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
por: Fang, Zhenhao, et al.
Publicado: (2022)

CONCERNING A POLYVALENT ANTIGEN FOR THE COMPLEMENT FIXATION TEST FOR STREPTOCOCCUS VIRIDANS INFECTION
por: Hastings, T. W.
Publicado: (1914)

Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach
por: Uttamrao, Patil Pranita, et al.
Publicado: (2021)

Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses
por: Wang, Shixia, et al.
Publicado: (2011)

Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen
por: Sakhatskyy, Pavlo, et al.
Publicado: (2006)

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
por: Budhadev, Darshita, et al.
Publicado: (2023)

Polyvalent vaccines: High-maintenance heroes
por: Schlingmann, Barbara, et al.
Publicado: (2018)

Polyvalent guide RNAs for CRISPR antivirals
por: Bagchi, Rammyani, et al.
Publicado: (2022)

Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case
por: König, Enrico, et al.
Publicado: (2021)

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
por: Luo, Yong, et al.
Publicado: (2020)

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus
por: Mosa, Alexander I., et al.
Publicado: (2023)

Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
por: Ribeiro-Viana, Renato, et al.
Publicado: (2012)

Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
por: Li, Wenjuan, et al.
Publicado: (2021)

The Reality of Critical Cancer Patients in a Polyvalent Intensive Care Unit
por: Neves, Maria Teresa, et al.
Publicado: (2021)

Erratum: Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
por: Ribeiro-Viana, Renato, et al.
Publicado: (2013)

Phenotypic and Genotypic Characterization of Novel Polyvalent Bacteriophages With Potent In Vitro Activity Against an International Collection of Genetically Diverse Staphylococcus aureus
por: Whittard, Elliot, et al.
Publicado: (2021)

Frascati : Le projet polyvalent ALFA-3
Publicado: (1982)

Recent Advances in Engineering Polyvalent Biological Interactions
por: Varner, Chad T., et al.
Publicado: (2014)

Characterization of two polyvalent phages infecting Enterobacteriaceae
por: Hamdi, Sana, et al.
Publicado: (2017)

The Polyvalent Role of NF90 in RNA Biology
por: Grasso, Giuseppa, et al.
Publicado: (2022)

Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens
por: Yefet, Ron, et al.
Publicado: (2023)

Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primates
por: Wu, Yi, et al.
Publicado: (2022)

A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1
por: Tetteh, Kevin K.A., et al.
Publicado: (2011)

Cross Neutralization of Afro-Asian Cobra and Asian Krait Venoms by a Thai Polyvalent Snake Antivenom (Neuro Polyvalent Snake Antivenom)
por: Leong, Poh Kuan, et al.
Publicado: (2012)

A Plant-Produced Antigen Elicits Potent Immune Responses against West Nile Virus in Mice
por: He, Junyun, et al.
Publicado: (2014)

Multifils et polyvalence: Les chambres proportionnelles multifils
Publicado: (1972)

Rapid polyvalent screening for largescale environmental Spiroplasma surveys
por: French, Frank E., et al.
Publicado: (2009)

NK Receptors: Tools for a Polyvalent Cell Family
por: Sivori, Simona, et al.
Publicado: (2014)

A Case of Endocarditis Treated with Polyvalent Antistreptococcus Serum
por: Chopra, R. N., et al.
Publicado: (1933)

Treatment of Pneumonia by a Polyvalent Stock Pneumococcic Vaccine
por: Charteris, Frank
Publicado: (1912)

Polyvalent vaccine approaches to combat HIV‐1 diversity
por: Korber, Bette, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u1jeu47m0lphgfodupf7obg7ck